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Summary Introduction
Spinal muscular atrophy (SMA) is an autosomal reces-Autosomal recessive spinal muscular atrophy (SMA) is
sive disorder with variable clinical severity and an over-classiﬁed, on the basis of age at onset and severity, into
all incidence of 1/6,000–1/10,000 (Dubowitz 1995).three types: type I, severe; type II, intermediate; and type
The disease primarily affects the anterior horn cells ofIII, mild. The critical region in 5q13 contains an inverted
the spinal cord, degeneration of which results in proxi-repeat harboring several genes, including the survival
mal muscle weakness. SMA is conventionally classiﬁed,motor neuron (SMN) gene, the neuronal apoptosis in-
on the basis of age at onset and severity, into three typeshibitory protein (NAIP) gene, and the p44 gene, which
(Munsat and Davies 1992; Dubowitz 1995). Werdnig-encodes a transcription-factor subunit. Deletion of
Hoffman disease, or type I SMA, is the most severe form,NAIP and p44 is observed more often in severe SMA,
with onset either in utero or during the ﬁrst few monthsbut there is no evidence that these genes play a role in the
of life. Affected children cannot sit unsupported, andpathology of the disease. In ú90% of all SMA patients,
death usually occurs at õ2 years of age. Type II SMAexons 7 and 8 of the telomeric SMN gene (SMNtel) are
usually manifests within the 1st year of life, and, al-not detectable, and this is also observed in some normal
though affected children may sit unaided, they do notsiblings and parents. Point mutations and gene conver-
achieve the ability to stand or walk independently. Thesions in SMNtel suggest that it plays a major role in the
survival of type II individuals depends on the degree ofdisease. To deﬁne a correlation between genotype and
respiratory complications. Kugelberg-Welander disease,phenotype, we mapped deletions, using pulsed-ﬁeld gel
or type III SMA, is a less severe form, characterized byelectrophoresis. Surprisingly, our data show that muta-
a later age at onset. Affected individuals have variabletions in SMA types II and III, previously classed as dele-
severity, walk independently, and may have a normaltions, are in fact due to gene-conversion events in which
life expectancy.SMNtel is replaced by its centromeric counterpart,
All three forms of childhood SMA map to the sameSMNcen. This results in a greater number of SMNcen
region on chromosome 5q13 (Brzustowicz et al. 1990;copies in type II and type III patients compared with
Gilliam et al. 1990; Melki et al. 1990a, 1990b). A num-type I patients and enables a genotype/phenotype corre-
ber of YAC physical maps spanning the SMA regionlation to be made. We also demonstrate individual
have been published, but it has not been possible toDNA-content variations of several hundred kilobases,
generate a consensus map of the region (Francis et al.even in a relatively isolated population from Finland.
1993; Kleyn et al. 1993; Carpten et al. 1994; Melki etThis explains why no consensus map of this region has
al. 1994; Roy et al. 1995b). This may be due to thebeen produced. This DNA variation may be due to a
fact that the critical region consists of many repeatedmidisatellite repeat array, which would promote the ob-
sequences, pseudogenes, and retrotransposable ele-served high deletion and gene-conversion rate.
ments, which may make the region unstable (Francis et
al. 1993, 1995; Sargent et al. 1994; Theodosiou et al.
1994; Selig et al. 1995). It also harbors a large inverted
duplication containing the survival motor neuron gene
(SMN) (Lefebvre et al. 1995) and the neuronal apoptosis
inhibitory-protein gene (NAIP) (Roy et al. 1995a) (seeReceived February 26, 1997; accepted for publication April 22,
ﬁg. 1A). The SMN gene encodes a novel protein with a1997.
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I (Hahnen et al. 1995; Roy et al. 1995a; Wirth et al.
1995; Burlet et al. 1996; Rodrigues et al. 1996; Velasco
et al. 1996).
It has been proposed that the SMA phenotype can be
modiﬁed by the presence of differing numbers of copies
of SMNcen. For example, studies have been carried out
on the parents of SMA patients to determine the
SMNcen:SMNtel dose ratio by densitometry of SSCP
bands (Velasco et al. 1996). As obligate carriers, the
parents were assumed to possess only one SMNtel gene.
The SMNcen:SMNtel dose ratio therefore reﬂected the
number of SMNcen copies. It was found that parents
of type II and type III patients carried more copies of
SMNcen than were carried by parents of type I patients.
However, in control individuals the total number ofFigure 1 A, Schematic representation of the duplicated region
SMNcen copies could not be assessed deﬁnitively, sinceon chromosome 5q13, containing the SMN and NAIP genes. NAIPC
a ratio of 1:1 could represent either two telomeric andÅ NAIP-pseudogene copy. The p44 gene is not represented, since it
is not considered a candidate gene for SMA. B, Illustration of the two centromeric genes or one copy of each. The
types of normal and mutant SMN alleles proposed. Gray-shaded and SMNcen:SMNtel copy ratio was also investigated by
unshaded boxes represent SMNcen and SMNtel gene copies, respec- solid-phase minisequencing (Schwartz et al. 1997). The
tively. A gray-shaded box in the SMNtel position represents a gene-
authors identiﬁed six predominant haplotypes, three forconversion event: SMNtel converted to SMNcen.
normal chromosomes and three for SMA chromosomes,
and proposed a disease model involving compound het-
erozygosity of these alleles. Although the genotype con-(Lefebvre et al. 1995) or by enzyme digestion of PCR
products (van der Steege et al. 1995). Although both taining three SMNcen copies was observed in SMA types
II and III, the authors had insufﬁcient evidence to corre-genes are transcribed, SMNtel is believed to be the im-
portant functional copy, since some exons of this gene late an increase in SMNcen copy number with a less
severe phenotype. It has also been demonstrated thatare not detectable in SMA patients (Hahnen et al. 1995;
Lefebvre et al. 1995; Rodrigues et al. 1995, 1996; Mat- the number of alleles of the multicopy marker C272 (or
Ag1CA) is an indicator of severity (DiDonato et al.thijs et al. 1996; Velasco et al. 1996). However, SMNcen
exons 7 and 8 are also undetectable in a minority of 1994; Melki et al. 1994; Lefebvre et al. 1995; Wirth et
al. 1995). Since the C272 marker lies at the 5 end ofnormal individuals (Hahnen et al. 1995; Lefebvre et al.
1995; Rodrigues et al. 1995; Matthijs et al. 1996). The each SMN gene, it should reﬂect the number of gene
copies. Alleles of C272 are deleted more often in type Itelomeric NAIP gene can be distinguished from its cen-
tromeric pseudogene counterpart by a PCR test for the SMA than in types II and III, suggesting that fewer SMN
copies remain in type I SMA. However, althoughpresence or absence of exon 5, which only exists within
the telomeric functional gene. Also contained within the SMNcen copy number is implicated in the variable se-
verity observed in SMA, none of the methods employedinverted duplicated region is the gene encoding p44, a
subunit of the basal transcription factor TFIIH (Humb- to date enable a deﬁnitive assessment of SMN copy num-
ber to be made both in SMA patients and in controlert et al. 1994). Deletion or interruption of this gene
is observed in 73% of type I SMA patients, but the individuals, and no method can distinguish between the
number of copies of SMNcen and the number of copiesobservation of deletions in parents and controls suggests
that this gene does not play a role in the disease pathol- of SMNtel.
In Ç5% of SMA patients, exon 7 of SMNtel is notogy. In addition, the protein structure and function ap-
pear normal in patients homozygously deleted for the detectable whereas exon 8 remains intact. (Cobben et al.
1995; Hahnen et al. 1995; Rodrigues et al. 1995, 1996).telomeric p44 gene (Bu¨rglen et al. 1997).
Although lack of ampliﬁcation of SMNtel exons 7 SMN genes in such individuals are the result of a gene-
conversion event, resulting in chimeric genes consistingand 8 is observed by PCR-based methods in ú90% of
all SMA patients, there has as yet been no correlation of SMNcen exon 7 linked to SMNtel exon 8 (Bussaglia
et al. 1995; Lefebvre et al. 1995; Devriend et al. 1996;between these apparent deletions and the severity of the
disease, most likely because the extent of deletion cannot Hahnen et al. 1996; van der Steege et al. 1996; Velasco
et al. 1996; DiDonato et al. 1997; Talbot et al., in press).easily be established, because of the presence of
SMNcen. Nonampliﬁcation of NAIP exon 5 is observed The partial gene conversion, not involving the entire gene,
that occurs in this minority of patients has been observedmore frequently in type I SMA than in types II and III,
suggesting the association of larger deletions with type in all SMA severities. Compound heterozygosity of multi-
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ple alleles has been proposed to account for the differ- In order to study the genomic variation of the SMA
region, blood was obtained from 7 unrelated Caucasianences in clinical expression of the disease (Wirth et al.
1995; Talbot et al. 1996; DiDonato et al. 1997), and it control individuals, as well as from 10 healthy blood
donors originating from northern Finland. Informedmay be that combinations of SMN gene deletions leading
to severe alleles and gene conversions leading to mild consent was obtained from all subjects prior to sam-
pling.alleles will result in variability of severity.
Nonampliﬁcation of exons of SMNtel has also been
SMN and NAIP PCR Deletion Analysisdescribed in asymptomatic siblings and parents of af-
SMN exon 7 and 8 deletion analysis was performedfected individuals (Cobben et al. 1995; Hahnen et al.
by the PCR and enzyme-digestion method described by1995; Wang et al. 1996). This observation has cast some
van der Steege et al. (1995). PCR was performed bydoubt on the role of SMNtel as the causative gene for
use of primers spanning SMN exons 7 and 8, and theSMA.We propose that gene-conversion events may have
products were digested with DraI and DdeI, respec-led to the replacement of SMNtel by SMNcen in such
tively. Digested products were run on 2.5% agarose gels,individuals, thereby leading to the existence of four cop-
and patients were scored as to their deletion status.ies of SMNcen. Since SMNcen is thought to produce a
NAIP exon 5 deletion analysis was performed by thesmall level of fully functional protein, four copies of this
method described by Roy et al. (1995a). Duplex PCRgene may produce enough functional protein to result
was performed by use of primers speciﬁc to NAIP exonsin a normal phenotype (see Discussion).
5 and 13, and patients were scored as positive or nega-In summary, the SMA region is highly complex, dis-
tive for NAIP exon 5, exon 13 being an internal control.crepancies exist in the YAC maps from different groups,
and the exact copy number of the genes in the region
PFGEcannot be reliably determined. Although the PCR-based
Genomic DNA was prepared from lymphocytes em-deletion analysis of SMN exons is an extremely useful
bedded in 0.6% low-gelling-temperature agarose blocksindicator of affected status, it cannot detect the extent
at a concentration of 107 cells/ml. After cell lysis andof deletion. We therefore chose to investigate gene copy
protein degradation in 0.5M EDTA (pH 8.0) containingnumber and the extent of DNA deletion in SMA pa-
1% SDS and 0.25 mg proteinase K,/ml at 50C for 48tients, using pulsed-ﬁeld gel electrophoresis (PFGE).
h, blocks were incubated at 37C for 2 h in Tris-EDTAThis also allowed us to test the hypothesis that the vari-
containing 2 mM Pefabloc (Boehringer Mannheim), toability in the physical maps might be due to genomic
inactivate proteinase K. Blocks were digested overnightvariation in the normal population.
with 40 U restriction enzyme, and the DNAwasanalyzedIn this paper we demonstrate the direct assessment of
on 1.2% pulsed-ﬁeld agarose gels for 40 h (pulse time 70SMN copy number by PFGE, enabling the identiﬁcation
s), by use of an LKB 2015 Pulsaphor system apparatusof those bands representing telomeric and centromeric
(Pharmacia). DNA was transferred to Hybond N/ mem-copies. We show the presence of a high degree of varia-
brane (Amersham) by capillary transfer in 0.4MNaOH.tion speciﬁc to the SMA region, in which fragment size
Probes used in the hybridization of pulsed-ﬁeld gels werecan vary by as much as 400 kb between individuals.
prepared by PCR ampliﬁcation using primers to exonsThis variation is inherited in a Mendelian fashion and
3 and 8 of the SMN gene and to exon 5 of the NAIPexists even in a highly inbred population. Its existence
gene. Ampliﬁed products were gel-puriﬁed (Geneclean;explains the lack of correlation between different physi-
Bio 101) and then were labeled to high speciﬁc activitycal maps of the region and suggests a high rate of change
by random priming (Pharmacia). Hybridization was per-in this region of the genome. The data obtained allow
formed at 65C in Church buffer (0.5 M NaHPO4 [pHus to make a hypothesis about the relationship between
7.2]/1 mM EDTA/7% SDS) overnight. Filters weregenotype and the severity of the SMA phenotype.
washed to a ﬁnal stringency of 0.5 1 SSC/0.1% SDS
at 65C.Material and Methods
DNA Resources Results
All patients conformed to internationally agreed diag-
Polymorphism in the SMA Regionnostic criteria (Munsat and Davies 1992). Lymphoblas-
toid cell lines (LCLs) were available from 15 unrelated In order to investigate the degree of variability in the
SMA region, probes corresponding to exon 3 of SMNSMA patients, of whom 5 were type I (1 from a consan-
guineous family), 7 were type II, and 3 were type III (SMN3) and to exon 5 of NAIP (NAIP5) were used
for hybridization of genomic DNA digested with rare-(1 consanguineous). Affected siblings and other family
members were available from some families. LCL con- cutting restriction enzymes. Figure 2 shows the analysis
of seven unrelated Caucasian normal individuals whosetrol samples were available from two non-SMA families.
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Figure 2 Analysis of normal individuals. EagI (a–c) and BssHII (d– f ) digests of DNA of seven unrelated Caucasian normal individuals,
hybridized with SMN3 (a and d), NAIP5 (b and e), and utrophin (c and f ) probes. Sizes (in kbp) relate to lambda-ladder PFG markers.
DNA was digested with either BssHII (ﬁg. 2a–c) or EagI band again relates to at least one copy of the gene. Thus,
it is possible to identify the SMN and NAIP cohybridiz-(ﬁg. 2d– f ). SMN exon 3 contains neither a BssHII nor
an EagI restriction site. Each band observed must there- ing bands as telomeric copies. The number of SMNtel
genes in the individuals shown is generally two. Thefore relate to at least one copy of the gene. In some
cases, where the band intensity appears greater than individual whose DNA is shown in lane 6 has three
bands hybridizing to NAIP5 but still has two SMNtelnormal, it may be that more than one band of the same
size is present, as is likely to be the case in lanes 4 and copies, since only two of the bands cohybridize with
SMN3. This is the case with both EagI and BssHII. In5 of ﬁgure 2d and e. Thus, hybridization with SMN3
shows that the total number of SMN gene copies among the case of EagI, the bands appear to be very similar in
size, but, when autoradiographs of both hybridizationsnormal individuals varies from three to four (ﬁg. 2a and
d). A high degree of variability was observed in the size were overlaid, one of the three bands was clearly of a
different size. Many NAIP pseudogenes consisting ofof hybridizing bands, the EagI bands varying in size
fromÇ200 kb toÇ600 kb in unrelated individuals. The various exons exist in the genome, and the third band
may represent such a sequence (Roy et al. 1995a). Wesame ﬁlters were subsequently hybridized with NAIP5,
which is contained only within the telomeric region of have subsequently observed three NAIP5 bands in 1/10
other control individuals. The pattern of bands observedthe SMA locus and which is lacking in the centromeric
NAIP pseudogene.(ﬁg. 2b and e) Exon 5 of the NAIP with either EagI or BssHII is very similar within each
individual, although the larger size range with BssHIIgene contains an EagI restriction site that we have found
to be methylated in genomic DNA (data not shown). indicates that this enzyme cuts outside the EagI sites.
These data suggest that restriction sites for both enzymesThe same exon does not contain any BssHII sites. Each
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occur on either side of each duplicated region containing
the SMN and NAIP genes. Hybridization of a probe
speciﬁc to the utrophin gene on chromosome 6 (ﬁg. 2c
and f ) shows a single band of the same size in all individ-
uals, indicating that the variability seen with SMN and
NAIP probes is not generated by partial digestion.
Mendelian Inheritance of SMA-Region Polymorphism
In order to determine whether the instability observed
is heritable, we analyzed eight members of a non-SMA
family, the results of which are presented in ﬁgure 3.
This BssHII digest was hybridized with the SMN3 (ﬁg.
3a) and NAIP5 probes (ﬁg. 3b). Seven members of the
family have four SMN copies, two of which, because of
cohybridization of SMN3 and NAIP5, are designated
telomeric. The individual whose DNA is shown in lane
5 shows only two SMN copies, one of which is telo-
meric, but he is believed to have inherited the same-size
bands from both parents. When this ﬁlter was hybrid-
ized with the utrophin probe, a band of lesser intensity
was observed in this lane, both indicating that less DNA Figure 4 Analysis of variation in northern Finnish control indi-
is present and accounting for the lack of dosage differ- viduals: EagI digests of DNA of 10 unrelated control individuals,
hybridized with SMN3 (a) and NAIP5 (b) probes. Lanes 8 and 9ence (data not shown). These data show that the varia-
show DNA from the same individual, run on different gels to allowtion in band size is inherited in a Mendelian
comparison. Sizes (in kbp) relate to lambda-ladder or yeast-chromo-fashion.
some PFG markers.
Variability within an Inbred Population
In view of the high degree of variation in the normal
population, it was of interest to determine whether a mutations might be expected to exist, would show a
highly inbred population, in which only a few founder lower degree of fragment-size variability. Since a number
of the individuals in our patient database originate from
Finland, we chose to investigate the size variability in
controls from one region of this inbred population.
Figure 4 shows the results obtained when EagI digests
of DNA from 10 northern Finnish non-SMA individuals
were hybridized to the SMN3 (ﬁg. 4a) and NAIP5
probes (ﬁg. 4b). The same type of variability was ob-
served as was seen in the seven non-Finnish control sam-
ples, and the total number of SMN copies again varied
from three to four. SMNtel copies in these controls var-
ied between one and three. The individual whose DNA
is shown in lanes 8 and 9 (DNA of the same individual
is present in both lanes), who has only one NAIP5-
hybridizing band, may be a carrier for the disease, hav-
ing only one SMNtel gene, or may have more than one
fragment of this size. The size of EagI bands in Finnish
control individuals varies between Ç180 kb and Ç600
kb, a size range similar to that observed in the non-
Finnish controls (see ﬁg. 2d and e). This amount of
variability in such an inbred population is indicative of
a high degree of instability within the SMA region.
Figure 3 Mendelian inheritance of the variation in a non-SMA
family. BssHII digests of DNA of eight members of a non-SMA family, PCR Deletion Analysis of SMN and NAIP
hybridized with SMN3 (a) and NAIP5 (b) probes. Lane 1, Father.
Deletion analysis of the SMN and NAIP genes wasLane 2, Mother. Lanes 3–8, Offspring. Sizes (in kbp) relate to lambda-
ladder PFG markers. performed on the patients to be analyzed by PFGE, as
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described in the Methods section. Patients were scored SMN3 and SMN8. Two of these SMN copies were des-
ignated telomeric, because of cohybridization withas to their deletion status for SMN exons 7 and 8 inde-
pendently. Patients were scored as positive or negative NAIP5.
In conclusion, type I chromosomes appear to resultfor NAIP exon 5, the telomeric-gene marker. A summary
of these results is presented in table 1. from the deletion of a large genomic region, encom-
passing SMN exon 3, SMN exon 8, and NAIP exon 5.
SMN Copy Number in SMA Type I Patients Since the distance between SMNtel and the telomeric
The copy number of SMN was investigated in the NAIP gene has been estimated to be Ç20 kb (Lefebvre
same ﬁve SMA type I patients as were analyzed by the et al. 1995), the minimum size of such a deletion would
PCR deletion method (see table 1). A blot containing be expected to be Ç70 kb.
EagI digests of the DNA of ﬁve SMA type I patients was
SMN Copy Number in SMA Type II and Type IIIhybridized to the SMN3 probe (ﬁg. 5a). The individual
Patientswhose DNA is shown in lane 5 is from a consanguineous
family. The total number of SMN gene copies was as- SMN copy number was investigated in the same seven
type II and three type III patients as were analyzed bysessed directly from the number of bands visible. Subse-
quent hybridization to the NAIP5 probe allowed identi- the PCR deletion method (see table 1). Southern blots
of EagI digests of DNA of these patients were hybridizedﬁcation of cohybridizing bands as telomeric copies (ﬁg.
5b). Type I individuals carry one or two SMN copies, to the SMN3 probe. The seven type II individuals and
two of the three type III SMA individuals carry two orof the centromeric type only, since none show cohybridi-
zation of NAIP5. This agrees with the PCR deletion data three SMN copies, one of which must exist within the
telomeric duplicated region, because of cohybridization(see table 1). So far, it had been assumed that any SMN
band not cohybridizing with NAIP exon 5 would be of NAIP5 (ﬁg. 6a and b). The individual whose DNA
is shown in lane 1 (SMA type III) is a patient from acentromeric. To conﬁrm this, a probe speciﬁc to SMN
exon 8 was hybridized to the same ﬁlter, and hybridiza- consanguineous family, who shows only one SMN
band, although it is of increased intensity, suggestingtion in the affected individuals was indeed observed only
to the bands previously believed to be centromeric (ﬁg. more than one copy of the same size. Hybridization of
other probes to this ﬁlter indicated a slight increase in5c). The control individual whose DNA is shown in
ﬁgure 5 showed four SMN bands, on hybridization to the amount of DNA in this lane compared with the
Table 1
Deletion Analysis of SMN and NAIP in SMA Patients
RESULT INb
SMN Exon 7 SMN Exon 8
NAIP:
PATIENTa Centromere Telomere Centromere Telomere Exon 5
I-1 / 0 / 0 0
I-2 / 0 / 0 0
I-3 / 0 / 0 0
I-4 / 0 / 0 0
I-5 / 0 / 0 0
I/II-1 / 0 / 0 /
II-2 / 0 / 0 /
II-3 / 0 / 0 /
II-4 / 0 / / /
II-5 / 0 / 0 /
II-6 / 0 / 0 /
II-7 / 0 / 0 /
III-1 / 0 / 0 0
III-2 / 0 / 0 /
III-3 / 0 / 0 /
a Designation consists of SMA type (roman numeral) and number assigned to individual (arabic numeral)
and correlates with that given in ﬁgures 5 and 6.
b A plus sign (/) denotes presence of a PCR product; and a minus sign (0) denotes absence of a PCR
product.
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could be explained if the SMNtel gene was not deleted
but, rather, was replaced by a copy of SMNcen by a
mechanism such as gene conversion (see Discussion).
Absence of SMNtel exon 7 but presence of SMNtel exon
8 was detected for the patient whose DNA is shown in
lane 4 of ﬁgure 6, suggesting that a partial gene conver-
sion has occurred.
Discussion
The data presented in this paper demonstrate that a
high degree of variability between individuals exists in
the SMA genomic region. In SMA types II and III, the
PCR-detected mutations previously classed as deletions
are likely to be the result of gene-conversion events, and
this results in an increase in SMNcen copies, SMNtel
having undergone gene conversion to SMNcen, which
correlates with severity of SMA phenotype.
We have shown that a genomic size variation in the
SMA gene region occurs in the normal population asFigure 5 Analysis of SMN gene copy number in SMA type I
well as in SMA patients and that it is inherited in apatients: EagI digests of DNA of ﬁve SMA type I patients, hybridized
with SMN3 (a), NAIP5 (b), and SMN8 (c) probes. Lane 5 shows Mendelian fashion. The Finnish control samples used in
DNA from a patient from a consanguineous family. con Å control this study originate from the province of Oulu in north-
individual. Sizes (in kbp) relate to lambda-ladder PFG markers. ern Finland, where several autosomal recessive diseases
belonging to the Finnish disease heritage are known to
be enriched. These include congenital chloride diarrhea,
others. However, this increase does not fully account lethal congenital contracture syndrome, nonketotic hy-
for the extra intensity observed on SMN exon 3 and perglycinemia, and northern epilepsy (Leisti et al. 1990;
exon 8 hybridization, and we conclude that this band
contains at least two SMNcen copies. This patient does
not carry a telomeric band, and it cannot be determined
whether the functional NAIP gene has been lost as a
result of a deletion or as a result of a gene-conversion
event. Thus, in all type II and type III patients except
the patient whose DNA is shown in lane 1 (SMA type
III), both hybridization and PCR deletion analysis sug-
gest the presence of NAIP exon 5. If deletion of the
telomeric duplicated region has occurred in these pa-
tients, it is not as large a deletion as is seen in type I
SMA, since NAIP exon 5 remains. In conclusion, the
total number of SMN copies in type II and type III
individuals appears to be greater than that in type I.
Gene Conversion of SMNtel to SMNcen in Type II and
Type III Chromosomes
SMN PCR deletion analysis showed an absence of
ampliﬁcation of SMNtel exons 7 and 8 in six of seven
type II patients and in all three type III patients, sug-
gesting deletion of these exons (see table 1). It was there- Figure 6 Analysis of SMN gene copy number in SMA type II
fore expected that the SMN exon 8–speciﬁc probe and type III patients: EagI digests of DNA of seven SMA type II
individuals and three SMA type III individuals, hybridized with SMN3would hybridize only to the SMNcen bands in these
(a), NAIP5 (b), and SMN8 (c) probes. Lane 1 (SMA type II) showspatients. As can be seen in ﬁgure 6c, this is not the case;
DNA of a patient whose phenotype is considered borderline betweenthe SMN8 probe hybridizes to the telomeric band as
type I and type II. Lane 1 (SMA type III) shows DNA from a patient
well as to the centromeric bands. This result conﬂicts from a consanguineous family. con Å control individual (the same
with the PCR deletion data, suggesting that exon 8 of individual as in ﬁg. 5). Sizes (in kbp) relate to lambda-ladder PFG
markers.SMNtel is not deleted. This discrepancy in the data
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de la Chapelle 1993). A high frequency of childhood this gene could be higher than that previously predicted
from the NAIP exon 5 deletion data.SMA is also observed in this region, the birth incidence
of SMA with onset at age õ12 mo being 1/7,100 and We have shown that nonconsanguineous type II and
type III SMA patients carry two or three copies of thethe estimated minimum carrier frequency being 1/42
(Ignatius 1992). The observation of genomic variability SMN gene, one of which, by cohybridization with the
NAIP exon 5 probe, appeared to be telomeric in origin.in the SMA region of this highly inbred Finnish popula-
tion indicates a high degree of instability within this PCR deletion analysis had revealed a lack of ampliﬁca-
tion of SMNtel exons 7 and 8, but hybridization of anregion. In view of these data, it is possible to speculate
on the existence of a midisatellite type of repeated se- SMN exon 8 probe to the telomeric band in these pa-
tients suggested that this duplicated region still pos-quence, the expansion and contraction of which, by a
method such as unequal crossing-over, could result in sessed a copy of SMN exon 8. Since the SMNtel and
SMNcen exons 7 and 8 are easily distinguishable by thethe formation of alleles differing in size by multiples of
the repeat size. One such sequence has been reported to PCR and enzyme-digestion method used in the deletion
analysis, we suggest that the exon 8 in question is indeedexist at a single locus on chromosome 1q, and PFGE
has shown the presence of allelic polymorphic fragments centromeric in origin. We propose that type II and type
III SMA mutant chromosomes occur as a result of gene-varying in size by as much as 250 kb, depending on the
enzymes used (Nakamura et al. 1987). Two such alleles conversion events in which SMNtel is converted to
SMNcen. In this way, patients do not possess a func-were observed in each individual. If a copy of a midisat-
ellite sequence exists associated with each SMN gene, tional SMNtel gene, although no physical DNA deletion
has occurred. Other genome regions containing dupli-we would expect to see four such variable alleles, as
indeed were observed when we used SMN gene probes. cated genes show a degree of gene-sequence conversion
in those patients in whom gene deletion is not observedThe presence of such a sequence would greatly enhance
the instability of the SMA region and could lead to an (Collier et al. 1989).
The number of copies of SMNcen is greater in typesincrease in the mutation rate, since the repeat could me-
diate mutations such as gene-deletion and -conversion II and III than in type I, since SMNtel copies are not
deleted but are converted to SMNcen. The greater num-events, resulting in the disease. Although the mechanism
of gene conversion is not known, the presence of repeat ber of SMNcen copies may serve to ameliorate the SMA
phenotype in the less severe phenotypes, types II and III.units may facilitate alignment of nonhomologous
strands, allowing sequence conversion, when one repeat Several groups have tested this hypothesis, using various
techniques, including investigation of the deletion of al-unit is used as template for DNA repair following strand
breakage. leles of the multicopy marker C272, which is contained
within the 5 end of each SMN gene (DiDonato et al.Our data substantiate those of other groups and sug-
gest that the majority of type I SMA cases do indeed 1994; Melki et al. 1994; Lefebvre et al. 1995; Wirth et
al. 1995). Correlation of the presence of fewer C272result from large-scale deletions, extending over§70 kb
and encompassing the SMN and NAIP genes. Our data alleles in type I SMA compared with types II and III
suggested that decreased copy number of C272 alleles—also show that type I SMA is characterized by the pres-
ence of one or two SMNcen genes only. The lack of and, therefore, of SMN—led to an increase in pheno-
typic severity. Wirth et al. also proposed a model basedhybridization of the NAIP exon 5 probe to any band
suggests that no telomeric genes exist in the type I SMA on the existence of mild and severe disease alleles and
on the suggestion that compound heterozygosity of thesefamilies examined.
Two possibilities exist to explain the role of NAIP in alleles results in varying severities of the disease. Velasco
et al. (1996) employed densitometry of SSCP bands tothe disease. It may be that, as a result of its proximity
to this gene, NAIP is coincidentally deleted along with observe an increased number of SMNcen copies in par-
ents of type II and type III patients, compared with par-SMNtel and that its presence or absence has no effect
on the disease phenotype. Deletion of NAIP exon 5 is ents of type I patients, and to suggest that this correlated
with a disease of lower severity in type II and type IIIobserved in 2% of SMA carriers and so can be associated
with a normal phenotype (Roy et al. 1995a). Alterna- offspring. In a further study, solid-phase minisequencing
was used to obtain an SMNtel:SMNcen ratio of genetively, NAIP deletion may contribute to the severity of
the phenotype, by generating an effect additive to that of copies (Schwartz et al. 1997). Although proposing a
model in which a number of normal and SMA haplo-SMNtel deletion. Indeed, deletion of NAIP is associated
more often with severe SMA than with intermediate or types exist, which, in combination, give rise to variable
disease severity, those authors were unable to correlatemild forms of the disease. In this study, the presence of
extra loci containing NAIP exon 5 was suggested in the number of SMNcen copies to severity. In addition,
it has been proposed that compound heterozygosity of2/17 control individuals. Such a ﬁnding, even in a small
number of samples, implies that the deletion rate for different disease alleles gives rise to the observation of
/ 9a2d$$ju01 07-03-97 16:05:15 ajhga UC-AJHG
48 Am. J. Hum. Genet. 61:40–50, 1997
different SMA severities within one family (Talbot et al. affecting this region result in SMA. Patients have been
described with mutations predicted to disrupt this region1996).
The data presented in this study suggest the existence and that would therefore be expected to disrupt this
motif (Lefebvre et al. 1995; Talbot et al. 1997). Otherof four SMA alleles, consisting of deletion of SMNtel in
addition to presence of one or no copies of SMNcen, or mutations result in premature truncation of the SMN
protein (Bussaglia et al. 1995; Brahe et al. 1996; Parsonsconversion of SMNtel to SMNcen in addition to pres-
ence of one or no copies of SMNcen. Figure 1B shows et al. 1996). Thus, SMA patients with either deletion of
SMNtel or gene conversion of SMNtel to SMNcen willa schematic representation of these alleles. Combina-
tions of these disease alleles would give rise to SMA produce a smaller-than-normal amount of functional
SMN protein, the amount being dependent on the num-phenotypes of varying severities; type I, for example,
would be the result of two chromosomes in which ber of SMNcen genes present.
It has been shown that the level of SMN protein de-SMNtel has been deleted. On the basis of this model,
for instance, this situation would be represented by a tectable on a western blot is much reduced in SMA type
I (Lefebvre et al. 1996). This result is in accordance withgenotype consisting of SMA alleles 1,2 or 2,2 (see ﬁg.
1B). SMA type I patients homozygous for the most se- our observation that a minimal number (one or two) of
SMNcen copies are carried by SMA type I individuals.vere allele, consisting of deletion of SMNtel and the
absence of SMNcen gene (genotype 1,1) are not ob- In contrast, an almost normal amount of SMN protein
is produced in type III patients, indicating a correlationserved, suggesting that this combination would be lethal
in utero. A similar model recently has been proposed by between the amount of SMN protein and the clinical
expression of the disease. The size difference betweenDiDonato et al. (1997), who observed a strong associa-
tion between the milder forms of SMA (types II and III) the proteins translated from the SMNcen full-length and
truncated transcripts is only 17 amino acids. It is notand partial gene-conversion events not involving exon
8. However, it should be noted that other groups have possible by conventional western analysis to distinguish
between the two resultant proteins. The observation ofobserved these events also in type I SMA (Hahnen et al.
1996; van der Steege et al. 1996; Velasco et al. 1996; an almost normal level of SMN protein in type III sug-
gests that the truncated protein is indeed translated. ItTalbot et al., in press). The observation of one NAIP5-
speciﬁc band in all but one of the type II and type III appears that, because of the presence of a greater num-
ber of SMNcen copies, an increased amount of fullypatients examined, in contrast to the two bands present
in most normal individuals, suggests that these patients functional protein is produced as the severity of the dis-
ease decreases.are compound heterozygotes with one deleted allele and
one gene-converted allele. Although we were unable to In this study we have highlighted a difference, in the
mechanism of formation, between SMA type I chromo-include in this study any type I patients who retain an
intact NAIP gene, it would be of interest to examine somes and those of types II and III. We have shown that
gene conversion plays a major role in type II and typesuch patients, in order to determine whether the lack of
ampliﬁcation of SMNtel exons in such a case would be III SMA. We propose that an increase in SMNcen copy
number leads to a decrease in severity of the disease, bydue to deletion or to gene conversion. The model pro-
posed by Emery (1991), in which one normal allele ex- the production of increased levels of functional SMN
protein, low levels of which are encoded by this gene.ists and combinations of at least four mutant alleles
could account for SMA types I–III, would have to be If this proves to be the case, as is also indicated by
the demonstration of the importance of SMNcen copymodiﬁed to include two normal alleles, consisting of one
SMNtel gene and either one or no SMNcen genes (see number in severity when the marker C272 (or Ag1CA)
is used, then the up-regulation of this centromeric geneﬁg. 1B).
Lefebvre et al. (1995) showed that transcription of could hold the key to future therapeutic advances
in SMA.SMNtel results in production of a full-length transcript,
thereby encoding a fully functional protein. SMNcen
transcription, on the other hand, results in an alternative
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